NCT00026949View on ClinicalTrials.gov

Study of Etoposide in Breast Cancer Patients

CompletedOBSERVATIONAL

Enrollment

33

Participants

Timeline

Start Date

August 31, 1999

Study Completion Date

August 31, 2004

Conditions

Breast Cancer

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00026949 - Study of Etoposide in Breast Cancer Patients | Biotech Hunter | Biotech Hunter